{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:27:03Z","timestamp":1792661223429,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TR001456"],"award-info":[{"award-number":["TR001456"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS067501"],"award-info":[{"award-number":["NS067501"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00415-016-8136-x","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T07:22:37Z","timestamp":1461568957000},"page":"1188-1194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes"],"prefix":"10.1007","volume":"263","author":[{"given":"H. A.","family":"Jinnah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Goodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami R.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Evatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"key":"8136_CR1","first-page":"77","volume-title":"Neurologic clinics","author":"HA Jinnah","year":"2015","unstructured":"Jinnah HA, Factor S (2015) Diagnosis and treatment of dystonia. In: Jankovic J (ed) Neurologic clinics. Elsevier, Amsterdam, pp 77\u2013100"},{"key":"8136_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/B978-0-444-52014-2.00037-9","volume":"100","author":"ML Evatt","year":"2011","unstructured":"Evatt ML, Freeman A, Factor S (2011) Adult-onset dystonia. Handb Clin Neurol 100:481\u2013511","journal-title":"Handb Clin Neurol"},{"key":"8136_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","volume":"67","author":"M Hallett","year":"2013","unstructured":"Hallett M, Albanese A, Dressler D et al (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 67:94\u2013114","journal-title":"Toxicon"},{"key":"8136_CR4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00415-015-7703-x","volume":"262","author":"A Albanese","year":"2015","unstructured":"Albanese A, Abbruzzese G, Dressler D et al (2015) Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement. J Neurol 262:2201\u20132213","journal-title":"J Neurol"},{"key":"8136_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3111\/13696998.2011.653726","volume":"15","author":"KD Sethi","year":"2012","unstructured":"Sethi KD, Rodriguez R, Olayinka B (2012) Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ 15:419\u2013423","journal-title":"J Med Econ"},{"key":"8136_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","volume":"12","author":"IM Skogseid","year":"2005","unstructured":"Skogseid IM, Kerty E (2005) The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 12:163\u2013170","journal-title":"Eur J Neurol"},{"key":"8136_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00415-014-7586-2","volume":"262","author":"C Comella","year":"2015","unstructured":"Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol 262:837\u2013848","journal-title":"J Neurol"},{"key":"8136_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","volume":"349","author":"J Jankovic","year":"2015","unstructured":"Jankovic J, Adler CH, Charles D et al (2015) Primary results from the cervical dystonia patient registry for observation of OnabotulinumtoxinA efficacy (CD PROBE). J Neurol Sci 349:84\u201393","journal-title":"J Neurol Sci"},{"key":"8136_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5334\/tohm.185","volume":"4","author":"VG Evidente","year":"2014","unstructured":"Evidente VG, Pappert EJ (2014) Botulinum toxin therapy for cervical dystonia: the science of dosing. Tremor Other Hyperkinet Mov 4:273","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"8136_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O (2002) Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17:1288\u20131293","journal-title":"Mov Disord"},{"key":"8136_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.parkreldis.2013.01.018","volume":"19","author":"SW Nijmeijer","year":"2013","unstructured":"Nijmeijer SW, Koelman JH, Standaar TS, Postma M, Tijssen MA (2013) Cervical dystonia: improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography. Parkinsonism Relat Disord 19:533\u2013538","journal-title":"Parkinsonism Relat Disord"},{"key":"8136_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/1531-8257(200001)15:1<150::AID-MDS1024>3.0.CO;2-X","volume":"15","author":"A Brashear","year":"2000","unstructured":"Brashear A, Bergan K, Wojcieszek J, Siemers ER, Ambrosius W (2000) Patients\u2019 perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A. Mov Disord 15:150\u2013153","journal-title":"Mov Disord"},{"key":"8136_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/toxins5040776","volume":"5","author":"CE Gill","year":"2013","unstructured":"Gill CE, Manus ND, Pelster MW et al (2013) Continuation of long-term care for cervical dystonia at an academic movement disorders clinic. Toxins (Basel) 5:776\u2013783","journal-title":"Toxins (Basel)"},{"key":"8136_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863\u2013873","journal-title":"Mov Disord"},{"key":"8136_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/mds.22157","volume":"23","author":"MF Brin","year":"2008","unstructured":"Brin MF, Comella CL, Jankovic J, Lai F, Naumann M (2008) Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 23:1353\u20131360","journal-title":"Mov Disord"},{"key":"8136_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WNF.0b013e3181914d0a","volume":"32","author":"O Lange","year":"2009","unstructured":"Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K (2009) Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol 32:213\u2013218","journal-title":"Clin Neuropharmacol"},{"key":"8136_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2014.09.034","volume":"21","author":"JJ Ferreira","year":"2015","unstructured":"Ferreira JJ, Colosimo C, Bhidayasiri R, Marti MJ, Maisonobe P, Om S (2015) Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia. Parkinsonism Relat Disord 21:111\u2013115","journal-title":"Parkinsonism Relat Disord"},{"key":"8136_CR18","first-page":"225","volume":"27","author":"JJ Ferreira","year":"2012","unstructured":"Ferreira JJ, Bhidayasiri R, Colosimo C, Marti MJ, Zakine B, Maisonobe P (2012) Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia. Funct Neurol 27:225\u2013230","journal-title":"Funct Neurol"},{"key":"8136_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00702-012-0893-9","volume":"120","author":"M Naumann","year":"2013","unstructured":"Naumann M, Boo LM, Ackerman AH, Gallagher CJ (2013) Immunogenicity of botulinum toxins. J Neural Transm 120:275\u2013290","journal-title":"J Neural Transm"},{"key":"8136_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/00207454.2012.668725","volume":"122","author":"C Coleman","year":"2012","unstructured":"Coleman C, Hubble J, Schwab J, Beffy JL, Picaut P, Morte C (2012) Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA. Int J Neurosci 122:358\u2013362","journal-title":"Int J Neurosci"},{"key":"8136_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00415-010-5880-1","volume":"258","author":"PJ Ruiz","year":"2011","unstructured":"Ruiz PJ, Castrillo JC, Burguera JA et al (2011) Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study. J Neurol 258:1055\u20131057","journal-title":"J Neurol"},{"key":"8136_CR22","doi-asserted-by":"crossref","unstructured":"Fabbri M, Leodori G, Fernandes RM et al (2015) Neutralizing antibody and Botulinum toxin therapy: A systematic review and meta-analysis. Neurotox Res (in press)","DOI":"10.1007\/s12640-015-9565-5"},{"key":"8136_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clineuro.2015.02.015","volume":"132","author":"M Svetel","year":"2015","unstructured":"Svetel M, Pekmezovic T, Tomic A, Kresojevic N, Kostic VS (2015) The spread of primary late-onset focal dystonia in a long-term follow up study. Clin Neurol Neurosurg 132:41\u201343","journal-title":"Clin Neurol Neurosurg"},{"key":"8136_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/archneur.1990.00530050070014","volume":"47","author":"M Jahanshahi","year":"1990","unstructured":"Jahanshahi M, Marion MH, Marsden CD (1990) Natural history of adult-onset idiopathic torticollis. Arch Neurol 47:548\u2013552","journal-title":"Arch Neurol"},{"key":"8136_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/mds.25088","volume":"27","author":"D Martino","year":"2012","unstructured":"Martino D, Berardelli A, Abbruzzese G et al (2012) Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia. Mov Disord 27:1447\u20131450","journal-title":"Mov Disord"},{"key":"8136_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00415-006-0457-8","volume":"254","author":"M Svetel","year":"2007","unstructured":"Svetel M, Pekmezovic T, Jovic J et al (2007) Spread of primary dystonia in relation to initially affected region. J Neurol 254:879\u2013883","journal-title":"J Neurol"},{"key":"8136_CR27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/mds.20919","volume":"21","author":"EM Weiss","year":"2006","unstructured":"Weiss EM, Hershey T, Karimi M et al (2006) Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord 21:1175\u20131181","journal-title":"Mov Disord"},{"key":"8136_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.410290407","volume":"29","author":"DJ Gelb","year":"1991","unstructured":"Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, Aminoff MJ (1991) Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 29:370\u2013376","journal-title":"Ann Neurol"},{"key":"8136_CR29","unstructured":"Waln O, LeDoux MS (2011) Blepharospasm plus cervical dystonia with predominant anterocollis: a distinctive subphenotype of segmental craniocervical dystonia? Tremor Other Hyperkinet Mov 2011(1). http:\/\/www.tremorjournal.org\/article\/view\/33"},{"key":"8136_CR30","first-page":"CR427","volume":"14","author":"S Papapetropoulos","year":"2008","unstructured":"Papapetropoulos S, Tuchman A, Sengun C, Russell A, Mitsi G, Singer C (2008) Anterocollis: clinical features and treatment options. Med Sci Monit 14:CR427\u2013CR430","journal-title":"Med Sci Monit"},{"key":"8136_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/mds.25567","volume":"7","author":"HA Jinnah","year":"2013","unstructured":"Jinnah HA, Berardelli A, Comella C et al (2013) The focal dystonias: current views and challenges for future research. Mov Disord 7:926\u2013943","journal-title":"Mov Disord"},{"key":"8136_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jns.2014.03.023","volume":"340","author":"GJ Revuelta","year":"2014","unstructured":"Revuelta GJ, Montilla J, Benatar M et al (2014) An (18)F-FDG PET study of cervical muscle in parkinsonian anterocollis. J Neurol Sci 340:174\u2013177","journal-title":"J Neurol Sci"},{"key":"8136_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2011.11.017","volume":"315","author":"GJ Revuelta","year":"2011","unstructured":"Revuelta GJ, Benatar M, Freeman A et al (2011) Clinical subtypes of anterocollis in parkinsonian syndromes. J Neurol Sci 315:100\u2013103","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"8136_CR34","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.parkreldis.2011.06.015","volume":"17","author":"R Bhidayasiri","year":"2011","unstructured":"Bhidayasiri R (2011) Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. Parkinsonism Relat Disord 17(Suppl 1):S20\u2013S24","journal-title":"Parkinsonism Relat Disord"},{"key":"8136_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.parkreldis.2009.01.006","volume":"15","author":"GA Glass","year":"2009","unstructured":"Glass GA, Ku S, Ostrem JL, Heath S, Larson PS (2009) Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord 15:610\u2013613","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"8136_CR36","doi-asserted-by":"publisher","first-page":"e000881","DOI":"10.1136\/bmjopen-2012-000881","volume":"2","author":"VP Misra","year":"2012","unstructured":"Misra VP, Ehler E, Zakine B, Maisonobe P, Simonetta-Moreau M, Group IIC (2012) Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. BMJ Open 2(3):e000881","journal-title":"BMJ Open"},{"key":"8136_CR37","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/mds.23905","volume":"26","author":"JM Flowers","year":"2011","unstructured":"Flowers JM, Hicklin LA, Marion MH (2011) Anterior and posterior sagittal shift in cervical dystonia: a clinical and electromyographic study, including a new EMG approach of the longus colli muscle. Mov Disord 26:2409\u20132414","journal-title":"Mov Disord"},{"key":"8136_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/WNF.0b013e318263163c","volume":"35","author":"RB Chinnapongse","year":"2012","unstructured":"Chinnapongse RB, Lew MF, Ferreira JJ, Gullo KL, Nemeth PR, Zhang Y (2012) Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials. Clin Neuropharmacol 35:215\u2013223","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8136-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8136-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:17:39Z","timestamp":1600467459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8136-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["8136"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8136-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]},"assertion":[{"value":"7 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest relating to the material presented in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This work has been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki, and has been approved by the Emory University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}